A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study

Clinical trial NCT03691649 · COMPLETED

Trial details

NCT number: NCT03691649
Sponsor: Santen Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glaucoma and Ocular Hypertension

Start date: 2018-09-14
Primary completion: 2019-12-06
Enrollment: 426

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.